Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 298, Issue 6, 2010, Pages

  Lu, Qing ^a   Harrington, Elizabeth O ^a   Newton, Julie ^a   Casserly, Brian ^a   Radin, Gregory ^a   Warburton, Rod ^a   Zhou, Yang ^b   Blackburn, Michael R ^b   Rounds, Sharon ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adenosine receptors; Adenosine transporters; Endothelium

Indexed keywords

1,3 DIPROPYL 7 METHYLXANTHINE; 1,3 DIPROPYLXANTHINE DERIVATIVE; 1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE; DIPYRIDAMOLE; GUANOSINE TRIPHOSPHATASE; HOMOCYSTEINE; ISOPRENYLCYSTEINE O CARBOXYL METHYLTRANSFERASE; METHYLTRANSFERASE; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; PENTOSTATIN; RAC1 PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LUNG EDEMA; LUNG ENDOTHELIUM; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE LUNG INJURY; ADENOSINE; ADENOSINE DEAMINASE; ADHERENS JUNCTIONS; ANIMALS; CATTLE; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; FOCAL ADHESIONS; LUNG; MALE; NUCLEOSIDE TRANSPORT PROTEINS; PENTOSTATIN; PULMONARY EDEMA; RAC1 GTP-BINDING PROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTORS, ADENOSINE A2; THIOUREA;

EID: 77952777259     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00330.2009     Document Type: Article

References (57)

1. Adkins WK, Barnard JW, May S, Seibert AF, Haynes J, Taylor AE. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J Appl Physiol 72: 492-497, 1992.
2. Adkins WK, Barnard JW, Moore TM, Allison RC, Prasad VR, Taylor AE. Adenosine prevents PMA-induced lung injury via an A2 receptor mechanism. J Appl Physiol 74: 982-988, 1993.
3. Allison RC, Hernandez EM, Prasad VR, Grisham MB, Taylor AE. Protective effects of O2 radical scavengers and adenosine in PMA-induced lung injury. J Appl Physiol 64: 2175-2182, 1988.
4. Baumer Y, Drenckhahn D, Waschke J. cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium. Histochem Cell Biol 129: 765-778, 2008.
5. Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J Cell Physiol 215: 715-724, 2008. (Pubitemid 351632693)
6. Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR, Birukov KG. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 313: 2504-2520, 2007.
7. Blackburn MR, Aldrich M, Volmer JB, Chen W, Zhong H, Kelly S, Hershfield MS, Datta SK, Kellems RE. The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. J Biol Chem 275: 32114-32121 2000.
8. Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, Lee JJ, Kellems RE. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192: 159-170, 2000. (Pubitemid 30470299)
9. Bradley JD, Zanaboni PB, Webster RO, Baudendistel LJ, Dahms TE. Adenosine prevents phorbol ester injury in rabbit lungs: role of leukotrienes and TNF. J Appl Physiol 71: 1949-1955, 1991.
10. Cagnina RE, Ramos SI, Marshall MA, Wang G, Frazier CR, Linden J. Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 297: L467-L474, 2009.
11. Carson MR, Shasby SS, Shasby DM. Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein. Am J Physiol Lung Cell Mol Physiol 257: L259-L264, 1989.
12. Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol 175: 1937-1946, 2005.
13. Cohen ES, Law WR, Easington CR, Cruz KQ, Nardulli BA, Balk RA, Parrillo JE, Hollenberg SM. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis. Am J Respir Crit Care Med 166: 16-20, 2002.
14. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105: 1950-1955, 2005.
15. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97, 1993. (Pubitemid 23187224)
16. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035, 2008. (Pubitemid 351451513)
17. Eckle T, Grenz A, Laucher S, Eltzschig HK. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118: 3301-3315, 2008.
18. Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915, 2009.
19. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505, 2005. (Pubitemid 41746596)
20. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, Odegard KC, Laussen PC, Thompson LF, Colgan SP. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108: 1602-1610, 2006. (Pubitemid 44316128)
21. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, Colgan SP. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796, 2003. (Pubitemid 37087777)
22. Factor P, Mutlu GM, Chen L, Mohameed J, Akhmedov AT, Meng FJ, Jilling T, Lewis ER, Johnson MD, Xu A, Kass D, Martino JM, Bellmeyer A, Albazi JS, Emala C, Lee HT, Dobbs LG, Matalon S. Adenosine regulation of alveolar fluid clearance. Proc Natl Acad Sci 104: 4083-4088, 2007.
23. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharm Rev 53: 527-552, 2001. (Pubitemid 33136237)
24. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25: 136-146, 2005. (Pubitemid 40039806)
25. Harrington E, Brunelle J, Shannon C, Kim E, Mennella K, Rounds S. Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. Am J Respir Cell Mol Biol 28: 626-636, 2003. (Pubitemid 36543410)
26. Harrington E, Shannon C, Morin N, Rowlett H, Murphy C, Lu Q. PKCδ regulates endothelial basal barrier function through modulation of RhoA GTPase activity. Exp Cell Res 308: 407-421, 2005. (Pubitemid 43300533)
27. Harrington EO, Newton J, Morin N, Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 287: L1091-L1097, 2004. (Pubitemid 39507184)
28. Haselton FR, Alexander JS, Mueller SN. Adenosine decreases permeability of in vitro endothelial monolayers. J Appl Physiol 74: 1581-1590, 1993. (Pubitemid 23133445)
29. Heller AR, Rothermel J, Weigand MA, Plaschke K, Schmeck J, Wendel M, Bardenheuer HJ, Koch T. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung. Eur J Anaesthesiol 24: 258-266, 2007.
30. Hill NS, O'Brien RF, Rounds S. Repeated lung injury due to alpha-naphthylthiourea causes right ventricular hypertrophy in rats. J Appl Physiol 56: 388-396, 1984. (Pubitemid 14143696)
31. Hill NS, Rounds S. Vascular reactivity is increased in rat lungs injured with alpha-naphthylthiourea. J Appl Physiol 54: 1693-1701, 1983. (Pubitemid 13060011)
32. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G, Herjavecz I, Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20: 1393-1398, 2002. (Pubitemid 35469046)
33. Klinger JR, Murray JD, Casserly B, Alvarez DF, King JA, An SS, Choudhary G, Owusu-Sarfo AN, Warburton R, Harrington EO. Rottlerin causes pulmonary edema in vivo: a possible role for PKCδ. J Appl Physiol 103: 2084-2094, 2007.
34. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20: 2242-2250, 2006. (Pubitemid 44953854)
35. Kutzsche S, Lyberg T, Bjertnaes LJ. Effects of adenosine on extravascular lung water content in endotoxemic pigs. Crit Care Med 29: 2371-2376, 2001. (Pubitemid 34038172)
36. Lo CM, Keese CR, Giaever I. Impedance analysis of MDCK cells measured by electric cell-substrate impedance sensing. Biophys J 69: 2800-2807, 1995.
37. Lu Q, Harrington EO, Hai CM, Newton J, Garber M, Hirase T, Rounds S. Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation. Circ Res 94: 306-315, 2004. (Pubitemid 38240721)
38. Martin C, Leone M, Viviand X, Ayem ML, Guieu R. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 28: 3198-3202, 2000.
39. Mohsenin A, Mi T, Xia Y, Kellems RE, Chen JF, Blackburn MR. Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am J Physiol Lung Cell Mol Physiol 293: L753-L761, 2007. (Pubitemid 47358838)
40. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580, 2008.
41. Neely CF, Jin J, Keith IM. A1-adenosine receptor antagonists block endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 272: L353-L361, 1997. (Pubitemid 27137276)
42. Paty PS, Sherman PF, Shepard JM, Malik AB, Kaplan JE. Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am J Physiol Heart Circ Physiol 262: H771-H777, 1992.
43. Perry M, Taylor AE. Phorbol myristate acetate-induced injury of isolated perfused rat lungs: neutrophil dependence. J Appl Physiol 65: 2164-2169, 1988. (Pubitemid 19012324)
44. Perry ML, Kayes SG, Barnard JW, Taylor AE. Effects of phorbol myristate acetate-stimulated human leukocytes on rat lung. J Appl Physiol 68: 235-240, 1990.
45. Richard LF, Dahms TE, Webster RO. Adenosine prevents permeability increase in oxidant-injured endothelial monolayers. Am J Physiol Heart Circ Physiol 274: H35-H42, 1998. (Pubitemid 28092564)
46. Ross SD, Tribble CG, Linden J, Gangemi JJ, Lanpher BC, Wang AY, Kron IL. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 18: 994-1002, 1999. (Pubitemid 29505488)
47. Rounds S, Farber HW, Hill NS, O'Brien RF. Effects of endothelial cell injury on pulmonary vascular reactivity. Chest 88: 213S-216S, 1985. (Pubitemid 16255474)
48. Siflinger-Birnboim A, Bode DC, Malik AB. Adenosine 3′,5′ -cyclic monophosphate attenuates neutrophil-mediated increase in endothelial permeability. Am J Physiol Heart Circ Physiol 264: H370-H375, 1993. (Pubitemid 23081105)
49. Sperlágh B, Dóda M, Baranyi M, Haskó G. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J Neuroimmunol 111: 45-54, 2000.
50. Stafford A. Potentiation of adenosine by dipyridamole. Nature 214: 390-391, 1967.
51. 2+ and adenylyl cyclase responses in phenotypically distinct pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 272: L51-L59, 1997.
52. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115: 35-43, 2005. (Pubitemid 40385503)
53. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, Lukashev D, Bittmann I, Sitkovsky MV. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3: 1088-1100, 2005. (Pubitemid 41032218)
54. Thorn JA, Jarvis SM. Adenosine transporters. Gen Pharmacol 27: 613-620, 1996.
55. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann NY Acad Sci 1123: 134-145, 2008.
56. Volmer JB, Thompson LF, Blackburn MR. Ecto-5′ -nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 176: 4449-4458, 2006.
57. Warren JB, Wilson AJ, Loi RK, Coughlan ML. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 7: 1394-1400, 1993.